www.parsebiosciences.comHealthcare / Healthcare providers & servicesFounded: 2018
Parse Biosciences, founded in 2018, is a biotechnology company that aims to provide researchers with single-cell solutions to streamline their experiments and discovery for objectives such as cancer treatment and stem cell therapy. Their Evercode products seek to use single-cell technology for gene capture at a greater scale and advanced data evaluation that strive to make it easier for researchers to quickly analyze results, all without having to use an instrument. Parse Biosciences is headquartered in Seattle, Washington.
View secondary pricing information, VWAP and distribution waterfall. And seek potentially outsized returns with same day private market data for private companies like Parse Biosciences.
Become part of the Secondary Marketplace, catering to both individual and institutional investors.